SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,264.58 |
| Enterprise Value ($M) | 645.75 |
| Book Value ($M) | 502.40 |
| Book Value / Share | 10.45 |
| Price / Book | 2.25 |
| NCAV ($M) | 445.07 |
| NCAV / Share | 8.28 |
| Price / NCAV | 2.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.08 |
| Current Ratio | 11.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 565.87 |
| Assets | 623.19 |
| Liabilities | 120.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 91.37 |
| Operating Income | -191.04 |
| Net Income | -147.03 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -133.91 |
| Cash from Investing | -2.77 |
| Cash from Financing | 45.10 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Fennell Todd W. | 5.85 | ||
| 13G | Scully William P | 6.53 | 42.20 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 7.90 | 32.35 | |
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Fmr Llc | 15.00 | 52.90 | |
| 13G/A | BlackRock Inc. | 7.00 | 8.19 | |
| 13G | State Street Corp | 5.14 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 76,804 | 472,563 | 16.25 | |
| 97,058 | 459,167 | 21.14 | |
| 112,321 | 204,105 | 55.03 | |
| 86,852 | 653,662 | 13.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMVP – PMV Pharmaceuticals, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated | PTCT – PTC Therapeutics, Inc. |
| PYXS – Pyxis Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io